Sector Chart BioCryst Pharmaceuticals, Inc.
Stocks
BCRX
US09058V1035
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 09/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.290 USD | -1.31% |
|
-0.48% | +6.28% |
| 05/10 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
| 05/10 | BioCryst Pharmaceuticals Forms Scientific Advisory Board as R&D Model Evolves | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 214.65Cr | - | - | - | ||
| 7.47TCr | |||||
| 5.87TCr | |||||
| 4.84TCr | |||||
| 4.31TCr | - | - | - | - | - |
| 4.25TCr |
Select your edition
All financial news and data tailored to specific country editions
